Best Irish Stocks To Invest In
Discover investment opportunities in Best Irish Stocks To Invest In using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Irish Stocks To Invest In using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Irish Stocks To Invest In using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best Irish Stocks To Invest In using our Smart AI Filter.
10 stocks found for "Best Irish Stocks To Invest In"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
0.94 Risk measure | ±29.2% Price volatility | 15.6 Valuation | 0.78% Annual yield | |||
0.55 Risk measure | ±27.3% Price volatility | 5.1 Valuation | 0.00% Annual yield | |||
0.82 Risk measure | ±34.0% Price volatility | 27.1 Valuation | 0.00% Annual yield | |||
0.47 Risk measure | ±33.4% Price volatility | 14.4 Valuation | 0.00% Annual yield | |||
0.74 Risk measure | ±24.7% Price volatility | 17.2 Valuation | 2.28% Annual yield | |||
0.71 Risk measure | ±39.9% Price volatility | 8.7 Valuation | 4.08% Annual yield | |||
0.18 Risk measure | ±34.3% Price volatility | 15.6 Valuation | 1.62% Annual yield | |||
0.00 Risk measure | ±0.0% Price volatility | 45.7 Valuation | 0.00% Annual yield | |||
0.36 Risk measure | ±21.7% Price volatility | 15.1 Valuation | 3.17% Annual yield | |||
0.85 Risk measure | ±24.2% Price volatility | 21.7 Valuation | 1.94% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Get a deeper insight into the potential performance of Northern Trust (NTRS) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Read moreWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read moreCRH (CRH) reached $92.88 at the closing of the latest trading day, reflecting a -1.39% change compared to its last close.
Read moreBDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.
Read moreThe consensus price target hints at a 33.2% upside potential for Alkermes (ALKS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read moreJazz Pharmaceuticals (NASDAQ: JAZZ) is currently trading at approximately $110, having decreased by 11% year-to-date, even after a significant positive development with the conditional European Commission Marketing Authorization for Ziihera (zanidatamab) aimed at advanced HER2-Positive Biliary Tract Cancer. Ziihera is the first HER2-targeted therapy approved in the EU for this condition, with anticipated peak annual sales surpassing $2 billion.
Read more